About Us
Vivesto is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer.
-
Regulatory November 16, 2023Interim report for the period January 1, 2023 – September 30, 2023
-
Regulatory October 25, 2023Vivesto focuses its project portfolio and introduces cost-saving measures
-
Regulatory September 15, 2023Delisting of Vivesto’s shares from Frankfurt Stock Exchange effective as of 15 September 2023
Vivesto published its Q3 report for 2023 on November 16, 2023, at 08.00 am CET.